Compare ATKR & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATKR | ANIP |
|---|---|---|
| Founded | 1959 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2016 | N/A |
| Metric | ATKR | ANIP |
|---|---|---|
| Price | $64.36 | $81.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $67.50 | ★ $102.14 |
| AVG Volume (30 Days) | ★ 624.1K | 417.1K |
| Earning Date | 02-03-2026 | 11-07-2025 |
| Dividend Yield | ★ 2.04% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.67 |
| Revenue | ★ $2,850,378,000.00 | $826,880,000.00 |
| Revenue This Year | $7.25 | $43.41 |
| Revenue Next Year | $3.79 | $9.66 |
| P/E Ratio | ★ N/A | $48.00 |
| Revenue Growth | N/A | ★ 48.87 |
| 52 Week Low | $49.92 | $52.50 |
| 52 Week High | $89.47 | $99.50 |
| Indicator | ATKR | ANIP |
|---|---|---|
| Relative Strength Index (RSI) | 47.98 | 41.87 |
| Support Level | $62.94 | $79.98 |
| Resistance Level | $66.88 | $83.00 |
| Average True Range (ATR) | 1.77 | 2.12 |
| MACD | 0.02 | 0.25 |
| Stochastic Oscillator | 30.09 | 33.67 |
Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.